Neuland Laboratories Ltd.

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1984

Chairman: Davuluri Rama Mohan Rao

Managing Director: Davuluri Rama Mohan Rao

Group: --

Listing: NSE: NEULANDLAB, BSE: 524558

Headquarters: Hyderabad, Telangana

Website: www.neulandlabs.com

Market cap: R 565.61 Cr

Revenue (TTM): R 743.73 Cr

Earnings (TTM): R 32.14 Cr

Cash: R 45.34 Cr

Total Debt: R 231.46 Cr

Promoters' ownership: 35.86%

Liquidity: High

52 Week range: R 380.25 - 827.30

Face value: R10.00

Shares outstanding: 1,28,29,889